Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06420206 · ClinicalTrials.gov registry record · NA

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

A NA study of Lung Cancer and Gastrointestinal Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06420206 is a NA study of Lung Cancer and Gastrointestinal Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06420206, a NA study of Lung Cancer and Gastrointestinal Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Interventions

  • OTHER Standard of Care (Acute Cancer Care Center)
  • OTHER Standard of Care (Goals of Care)

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-05-14
Est. Completion 2027-02-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06420206

The ClinicalTrials.gov registry entry for NCT06420206 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care (Acute Cancer Care Center) is the first listed.

NCT06420206 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06420206 about?

NCT06420206 is a clinical study titled "Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center". To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

What is the current status of trial NCT06420206?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-05-14. Estimated completion is 2027-02-02.

What conditions does trial NCT06420206 study?

This clinical trial studies the following conditions: Lung Cancer, Gastrointestinal Cancer.

What interventions are being tested in trial NCT06420206?

The interventions under investigation include: Standard of Care (Acute Cancer Care Center) (OTHER), Standard of Care (Goals of Care) (OTHER).

Who is sponsoring clinical trial NCT06420206?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06420206 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.